Jingsheng Hua

Donor-derived anti-CD19 CAR T cells compared with donor lymphocyte infusion for recurrent B-ALL after allogeneic hematopoietic stem cell transplantation

Jingsheng Hua, Jian Zhang, Xinyou Zhang et al. · Bone Marrow Transplantation · 2020 · 32 citations

Radiation Oncology, Cell Therapy, Transplantation +12

Early Death and Survival of Patients With Acute Promyelocytic Leukemia in ATRA Plus Arsenic Era: A Population-Based Study

Hong‐Hu Zhu, Yafang Ma, Yu Kang et al. · Frontiers in Oncology · 2021 · 26 citations · Full text

Allogeneic Donor-Derived Anti-CD19 CAR T Cell Is a Promising Therapy for Relapsed/Refractory B-ALL After Allogeneic Hematopoietic Stem-Cell Transplantation

Jingsheng Hua, Jian Zhang, Xiaoxia Wu et al. · Clinical Lymphoma Myeloma & Leukemia · 2020 · 22 citations

Cell Therapy, Transplantation, Marrow Transplantation +13

Dysfunction of microRNA-32 regulates ubiquitin ligase FBXW7 in multiple myeloma disease

Jingsheng Hua, Tianling Ding, Lin Yang · OncoTargets and Therapy · 2016 · 17 citations · Full text

Immunology, Pathology, Cancer Biology +21

<p>Sequential Infusion of Anti-CD22 and Anti-CD19 Chimeric Antigen Receptor T Cells for a Pediatric Ph-Like B-ALL Patient That Relapsed After CART-Cell and Haplo-HSCT Therapy: A Case Report and Review of Literature</p>

Jingsheng Hua, Weiqing Qian, Xiaoxia Wu et al. · OncoTargets and Therapy · 2020 · 13 citations · Full text

Clinical Immunology, Haplo-hsct Therapy, Cell Therapy +18